Healthy
Behaviors Extend Life After Cancer, Experts Say
Eating well,
exercising and maintaining normal weight boost survival, American Cancer
Society finds.
By Jenifer Goodwin. In U.S. News & World Report
Aspirin
after bowel cancer diagnosis reduces chance of dying by 30 per cent
Taking
aspirin after being diagnosed with bowel cancer can reduce the chance of dying
from the disease by 30 per cent, new research shows today.
In Cancer Research UK
(press release)
FDA approves
Glaxo cancer drug Votrient
U.S.
regulators gave the nod to GlaxoSmithKline Plc's Votrient for a type of sarcoma
on Thursday, following a positive advisory panel vote last month.
In Reuters.
FDA rejects
Amgen's application for Xgeva
U.S. health
regulators rejected the application by Amgen Inc, the world's biggest
biotechnology company, to expand the use of the drug Xgeva to delay the spread
of tumors to the bone in patients suffering from advanced prostate cancer.
In Reuters.
Gene
Critical to Development and Spread of Lung Cancer Identified
A single
gene that promotes initial development of the most common form of lung cancer
and its lethal metastases has been identified by researchers at Mayo Clinic in Florida . Their study
suggests other forms of cancer may also be driven by this gene, matrix
metalloproteinase-10 (MMP-10).
In Science Daily
Post-cancer
fatigue “overestimated"
Despite
widespread belief to the contrary, as few as 6% of women experience
cancer-related persistent fatigue a year after undergoing treatment for breast
cancer, a new study has found.
In ScienceAlert
Stanford Web
tool helps patients weigh cancer risk
Four years
ago, Raychel Kubby Adler opted to have a prophylactic double mastectomy because
of a genetic mutation that gave her an 87 percent lifetime chance of developing
breast cancer. Now, the mother of two daughters and a wellness coach in Davis is considering
having her ovaries removed.
By Victoria Colliver. In San Francisco Chronicle
Fewer
Complications, Better Outcomes With Robot-Assisted Prostate Cancer Surgery
Robot-assisted
surgery is now both more common and far more successful than radical
"open" surgery to treat prostate cancer in the United States , according to a new Henry Ford
Hospital study published
in the current issue of the medical journal European Urology.
In Science Daily
Cancer:
Choosing Quality of Life Over Aggressive Treatment
Amy Berman
was diagnosed with terminal inflammatory breast cancer 18 months ago. To
preserve her quality of life, Berman decided against aggressive treatment of
her disease in favor of palliative care.
By Amy Berman. In Washington
Post
Anxiety
increases cancer severity in mice, study shows
Worrywarts,
fidgety folk and the naturally nervy may have a real cause for concern:
accelerated cancer. In a new study led by researchers at the Stanford University
School of Medicine,
anxiety-prone mice developed more severe cancer then their calm counterparts.
In Science Daily
Pourquoi les hommes ont plus de
cancers que les femmes
Les hommes sont les premières victimes des cancers. Et comme
le montre une récente étude, le constat s'applique à tous les types de cancers.
Seules exceptions : ceux qui touchent les organes génitaux (utérus...) et la
thyroïde.
Par Didier Raoult. Dans Le Point
Cancer de la prostate L'espoir des
ultrasons
Des résultats prometteurs ont été obtenus en Grande-Bretagne
sur 41 patients présentant une petite tumeur localisée.
Sur
El Watan
Des images 3D des
tissus pour repérer et traiter le cancer
Un dépistage plus précoce du cancer serait possible grâce à
une nouvelle technique d’imagerie en 3D. Dans leur publication du American
Journal of Pathology, ils décrivent leur méthode de microscopie digitale.
Dans
Maxi-Sciences
Cancer du sein : pas une, mais dix
maladies différentes
Identifiées par des chercheurs de Cambridge, ces formes
nécessitent chacune un traitement particulier.
Par Damien Mascret. Dans Le Figaro
Cancer de la prostate: le dépistage
sanguin sans intérêt
Nouvel élément d’importance dans la controverse sur les modalités pratiques du dépistage du
cancer de la prostate: le dépistage régulier (par voie sanguine) ne présente
pas de véritable intérêt, et ce y compris chez les hommes considérés comme
étant «à haut risque» pour cette lésion maligne.
Dans Slate.fr
Aucun commentaire:
Enregistrer un commentaire